Tomoko Seki – 研究成果 — Keio University

Scopus著者プロファイル

ウェブサイトhttps://k-ris.keio.ac.jp/html/100003608_ja.html

h-index

年別の研究成果

Pureに変更を加えた場合、すぐここに表示されます。

15 Article
3 Review article

15 件

フィルター

2022
Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical application
Hayashida, T., Odani, E., Kikuchi, M., Nagayama, A., Seki, T., Takahashi, M., Futatsugi, N., Matsumoto, A., Murata, T., Watanuki, R., Yokoe, T., Nakashoji, A., Maeda, H., Onishi, T., Asaga, S., Hojo, T., Jinno, H., Sotome, K., Matsui, A., Suto, A., & 2 othersImoto, S. & Kitagawa, Y., 2022 10月, In: Cancer science. 113, 10, p. 3528-3534 7 p.
研究成果: Article › 査読

Open Access
1 被引用数 (Scopus)
Feasibility study on collecting patient-reported outcomes from breast cancer patients using the LINE-ePRO system
Hayashida, T., Nagayama, A., Seki, T., Takahashi, M., Matsumoto, A., Kubota, A., Jinno, H., Miyata, H. & Kitagawa, Y., 2022 5月, In: Cancer science. 113, 5, p. 1722-1730 9 p.
研究成果: Article › 査読

Open Access
1 被引用数 (Scopus)
The relationship between work-related outcomes and symptoms in early breast cancer survivors receiving adjuvant endocrine therapy
Nakao, M., Komatsu, H., Hayashida, T., Takahashi, M., Seki, T. & Yagasaki, K., 2022 3月, In: Asia-Pacific Journal of Oncology Nursing. 9, 3, p. 174-178 5 p.
研究成果: Article › 査読

Open Access
2021
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin
Teng, X., Hayashida, T., Murata, T., Nagayama, A., Seki, T., Takahashi, M. & Kitagawa, Y., 2021 7月, In: Breast Cancer. 28, 4, p. 884-895 12 p.
研究成果: Article › 査読
2 被引用数 (Scopus)
Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development
Nakashoji, A., Hayashida, T., Yamaguchi, S., Kawai, Y., Kikuchi, M., Yokoe, T., Nagayama, A., Seki, T., Takahashi, M. & Kitagawa, Y., 2021 4月, In: Breast Cancer Research and Treatment. 186, 2, p. 353-361 9 p.
研究成果: Article › 査読
4 被引用数 (Scopus)
Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US)
Maeda, H., Hayashida, T., Watanuki, R., Kikuchi, M., Nakashoji, A., Yokoe, T., Seki, T., Takahashi, M. & Kitagawa, Y., 2021 3月, In: Breast Cancer. 28, 2, p. 398-404 7 p.
研究成果: Article › 査読
1 被引用数 (Scopus)
2020
Identification of a Modified HOXB9 mRNA in Breast Cancer
Nakashoji, A., Hayashida, T., Kawai, Y., Kikuchi, M., Watanuki, R., Yokoe, T., Seki, T., Takahashi, M., Miyao, K., Yamaguchi, S. & Kitagawa, Y., 2020, In: Journal of Oncology. 2020, 6065736.
研究成果: Article › 査読

Open Access
1 被引用数 (Scopus)
Impact of neoadjuvant and adjuvant chemotherapy on invasive lobular carcinoma: A propensity score-matched analysis of SEER data
Watanuki, R., Hayashida, T., Yokoe, T., Kawai, Y., Kikuchi, M., Nakashoji, A., Nagayama, A., Seki, T., Takahashi, M. & Kitagawa, Y., 2020 9月 1, In: Breast Journal. 26, 9, p. 1765-1770 6 p.
研究成果: Article › 査読

Open Access
3 被引用数 (Scopus)
Increased frequency of ESR1 mutation in metastatic breast cancer by dosing selective estrogen receptor modulator followed by aromatase inhibitor
Takeshima, K., Hayashida, T., Maeda, H., Nakashoji, A., Yokoe, T., Seki, T., Takahashi, M. & Kitagawa, Y., 2020 8月, In: Oncology Letters. 20, 2, p. 1231-1238 8 p.
研究成果: Article › 査読

Open Access
2019
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients
Watanuki, R., Hayashida, T., Kawai, Y., Kikuchi, M., Nakashoji, A., Yokoe, T., Toyota, T., Seki, T., Takahashi, M. & Kitagawa, Y., 2019 7月 12, In: International Journal of Clinical Oncology. 24, 7, p. 807-814 8 p.
研究成果: Article › 査読
2 被引用数 (Scopus)
2018
IgG4-related mastopathy: A case report and literature review
Yokoe, T., Hayashida, T., Kikuchi, M., Watanuki, R., Nakashoji, A., Maeda, H., Toyota, T., Seki, T., Takahashi, M., Iwasaki, E., Mikami, S., Kameyama, K. & Kitagawa, Y., 2018 8月, In: Clinical Case Reports. 6, 8, p. 1549-1553 5 p.
研究成果: Article › 査読

Open Access
12 被引用数 (Scopus)
Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial
Hayashida, T., Jinno, H., Mori, K., Sato, H., Matsui, A., Sakurai, T., Hattori, H., Takayama, S., Wada, M., Takahashi, M., Seki, H., Seki, T., Nagayama, A., Matsumoto, A. & Kitagawa, Y., 2018 6月 28, In: BMC cancer. 18, 1, 701.
研究成果: Article › 査読

Open Access
13 被引用数 (Scopus)
2016
A randomized controlled study comparing a vessel sealing system with the conventional technique in axillary lymph node dissection for primary breast cancer
Seki, T., Hayashida, T., Takahashi, M., Jinno, H. & Kitagawa, Y., 2016 12月 1, In: SpringerPlus. 5, 1, 1004.
研究成果: Article › 査読

Open Access
12 被引用数 (Scopus)
2015
Comparison of oncological safety between nipple sparing mastectomy and total mastectomy using propensity score matching
Seki, T., Jinno, H., Okabayashi, K., Murata, T., Matsumoto, A., Takahashi, M., Hayashida, T. & Kitagawa, Y., 2015, In: Annals of the Royal College of Surgeons of England. 97, 4, p. 291-297 7 p.
研究成果: Article › 査読
15 被引用数 (Scopus)
Prognostic implications of receptor discordance between primary and recurrent breast cancer
Matsumoto, A., Jinno, H., Murata, T., Seki, T., Takahashi, M., Hayashida, T., Kameyama, K. & Kitagawa, Y., 2015 8月 8, In: International Journal of Clinical Oncology. 20, 4, p. 701-708 8 p.
研究成果: Article › 査読
26 被引用数 (Scopus)